P-Shot for Sexual Enhancement: Evidence, Limits and Risks
Updated: Aug 19
The P-Shot is a marketed name for injections of platelet-rich plasma (PRP) prepared from a person’s own blood. It is sometimes promoted for stronger erections, greater sensitivity, improved sexual performance or increased penile size. Those claims should be separated carefully: a biological rationale is not the same as reliable clinical proof.
For men considering a P-Shot in London, the most useful first step is a proper sexual-health assessment. Symptoms can have vascular, hormonal, neurological, medication-related or psychological causes, and treatment should address the likely cause rather than begin with a procedure package.
What is a P-Shot?
A small blood sample is processed in a centrifuge to concentrate platelets in plasma. The resulting PRP is then injected into selected penile tissues using local anaesthesia. Preparation systems, platelet concentrations, injection sites and follow-up schedules vary. There is no universally standardised P-Shot protocol, so studies and clinic claims are not always directly comparable.
Because PRP is autologous, allergic reactions are considered uncommon. However, an injection is still a medical procedure. Autologous does not mean risk-free, proven or suitable for every patient.
What does the evidence show?
Small studies have explored PRP for erectile dysfunction, and some report changes in erectile-function questionnaires. The studies differ in design, patient selection, PRP preparation and follow-up. This makes it difficult to know how much benefit is due to the treatment, how long any effect lasts, and which patients are most likely to respond.
Current European urology guidance regards the evidence for platelet-rich plasma in erectile dysfunction as insufficient for routine clinical recommendation and advises use in a clinical-trial setting. This is different from established treatments such as lifestyle and risk-factor management, PDE5 inhibitor tablets when appropriate, vacuum erection devices, intracavernosal injections and penile prosthesis surgery for selected patients.
Claims about sensitivity, stamina and penile size
• Sensitivity: reliable evidence that PRP predictably increases penile sensitivity or improves orgasm is lacking.
• Sexual stamina: there is no good evidence that a P-Shot routinely improves desire, ejaculation control or performance in men without a diagnosed problem.
• Length or girth: PRP should not be presented as an established penile-enlargement treatment. Temporary swelling after an injection is not evidence of permanent growth.
• Erections: any possible benefit remains uncertain, and it should not be described as a cure or guaranteed response.
Why assessment comes before treatment
Persistent erectile problems can sometimes be an early marker of cardiovascular or metabolic disease. A consultation may review onset, morning erections, libido, ejaculation, penile pain or curvature, medical conditions, medicines, alcohol, smoking, sleep, stress and relationship factors. Blood pressure, genital examination and targeted blood tests may be appropriate.
Tests are selected according to the history. They may include glucose or HbA1c, lipids and a fasting morning testosterone level. Testosterone deficiency should not be diagnosed from symptoms alone or from a single untimed result.
What happens during the procedure?
If PRP is considered after informed discussion, the visit normally includes consent, blood collection, processing and injection under a local or topical anaesthetic. The clinician should explain the exact product, number of injections, expected aftercare, total cost and what will happen if there is no improvement.
Patients should not be promised immediate or permanent results. Follow-up should use defined outcomes, such as a validated erectile-function score, rather than vague statements about rejuvenation.
Possible risks and reasons to postpone treatment
Potential harms include pain, bruising, swelling, bleeding, infection, altered sensation and disappointment or financial loss if the treatment does not help. People taking anticoagulants or antiplatelet medicines, those with bleeding or platelet disorders, active infection, uncontrolled medical illness or concerning penile symptoms require individual assessment. Prescribed medicines should never be stopped without advice from the clinician who manages them.
Urgent medical help is appropriate for an erection lasting four hours or more, severe increasing pain, fever, spreading redness, heavy bleeding or rapidly worsening swelling.
Alternatives to discuss
The best option depends on the diagnosis and the patient’s goals. Evidence-based care may include exercise, weight and smoking support, management of diabetes or blood pressure, review of contributing medicines, psychosexual support, PDE5 inhibitors, a vacuum device, penile injections or surgery. Low-intensity shockwave therapy may be discussed for selected men with mild vasculogenic erectile dysfunction, but the average benefit is modest and the recommendation is weak.
Questions to ask a clinic
• What diagnosis is being treated, and how was it established?
• Is the proposed use of PRP established, investigational or part of a registered clinical trial?
• Which outcomes are realistic, and how will they be measured?
• What are the alternatives, risks, full costs and follow-up arrangements?
• Who performs the injection, and what is their professional registration?
Frequently asked questions
Can a P-Shot increase penis size?
There is no reliable evidence that PRP produces predictable permanent increases in penile length or girth. Claims of enlargement should be treated cautiously.
Can it improve sensitivity?
Evidence is not strong enough to promise improved sensitivity. Reduced sensation can have neurological, metabolic, medication-related or psychological causes that require assessment.
Is PRP approved as a standard ED treatment?
PRP is not recommended as routine treatment for erectile dysfunction in current European guidance because the evidence remains insufficient. Regulatory status and clinical evidence are separate questions; patients should receive clear information about both.
Related London guides
About the author
Dr Fabio Castiglione
Consultant Urologist and Andrologist in London. Holistic Andrology, 9 Harley Street, London W1G 9QY.
GMC reference number: 7541824
Medical review and sources
Medically reviewed by Dr Fabio Castiglione on 19 August 2026. This article is general information, not a diagnosis or a guarantee of benefit. Recommendations may change as new evidence emerges.
Comments